Aspect Partners’s GSK GSK Stock Holding History

Aspect Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-240	Closed	-$9.22K	–	718
2025 Q2	$9.22K	Buy	+240	New	+$9.17K	﹤0.01%	295
2024 Q4	–	Sell	-80	Closed	-$3.27K	–	610
2024 Q3	$3.27K	Hold	80	–	–	﹤0.01%	405
2024 Q2	$3.08K	Hold	80	–	–	﹤0.01%	409
2024 Q1	$3.43K	Hold	80	–	–	﹤0.01%	393
2023 Q4	$2.96K	Buy	+80	New	+$2.87K	﹤0.01%	393

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aspect Partners's GSK Position: Q3 2025 in Review

Aspect Partners sold out of GSK (GSK) in Q3 2025, closing a stake of 240 shares — an estimated $9.22K sold.

Aspect Partners first reported a position in GSK in Q4 2023 and held it in 5 quarters. The position peaked at $9.22K in Q2 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Aspect Partners reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Aspect Partners sold 240 GSK shares in Q3 2025, an estimated $9.22K.
Aspect Partners first reported a position in GSK in Q4 2023 and held it in 5 quarters.
Aspect Partners's GSK position peaked at $9.22K in Q2 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Aspect Partners's 13F filing for Q3 2025, filed 6 Nov 2025.